Journals / Retina-Vitreus / 2003 / Cilt: 11 - Sayı: 3

The relation between sialic acid elevation and retinopathy in type II diabetic patients

Tip II diyabetik hastalarda retinopati derecesi ve serum siyalik asit düzeyi ilişkisi

Pages
235–242
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: There is no correlation between grading of retinopathy and serum sialic acid level.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Increased serum concentration of sialic acid is a marker of the acute-phase response.
📊
Key Findings & Data:Methods: Type II diabetic 49 patient(F/M- 30/19, mean age 56±7 years old) were included in this study.
💡
Conclusion & Impact:Conclusions: There is no correlation between grading of retinopathy and serum sialic acid level.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Diabetes mellitus · insülin bağımsız · Akut faz reaksiyonu

Abstract

Purpose: Increased serum concentration of sialic acid is a marker of the acute-phase response. Elevated concentrations of sialic acids in type Il diabetic patients have been shown in previous studies. The aim of this study is to determine the relation between sialic acid elevation and diabetic retinopathy. Methods: Type II diabetic 49 patient(F/M- 30/19, mean age 56±7 years old) were included in this study. The patients were divided into three groups; patients without retinopathy (Group RO, n: 19), patients with nonproliferative retinopathy (Group R1, n: 15) and patients with proliferative retinopathy (Group R2, n: 15). Healthy 38 volunteers were included as control group (F/M, 19/19, 55±6 years old). Results: A significant difference (P<0.05) was observed in serum sialic acid values in diabetic patients (R0=2.00±0.47, R1=2.17±0.30, R2= 2.25±0.5 mmol/L) compared with healthy controls (C=1.81±0.30 mmol/L). Serum sialic acid level was higher in the nonproliferative retinopathy group but the difference between groups was not statistically insignificant (P>0.05). Conclusions: There is no correlation between grading of retinopathy and serum sialic acid level.

Özet

Amaç: Serum siyatik asit ( N-acetyl neuraminic acid) konsantrasyonu akut-faz yanıtının bir belirtecidir. Tip II diyabeti olan hastaların kanında siyalik asit düzeylerinin arttığı gösterilmiştir. Bu çalışmanın amacı serum siyalik asit artışı ve diyabetik retinopati arasındaki ilişkiyi araştırmaktır. Metod: Bu çalışmaya 49 tip II diyabetik hasta dahil edildi (K/E - 30/19, yaş ortalaması 56$pm$7 yıl). Hastalar retinopatisi olmayanlar (Grup RO, n: 19), nonproliferatif retinopatisi olanlar (Grup R1, n: 15) ve proliferatif retinopatisi olanlar (Grup R2, n: 15) olmak üzere 3 grupta değerlendirildi. Sağlıklı 38 denek (K/E, 19/19, 55$pm$6 yaş) kontrol grubu olarak alındı. Kan siyalik asit düzeyi Svennerholm metoduna dayalı spektro-fotometrik yöntem He çalışıldı. Yaş, diyabet süresi, vücut kitle indeksi, total kolesterol, HDL, trigliserit, Hb A 1c, açlık kan şekeri, kretinin klerens, fibrinojen, lökosit incelemeye dahil edildi. Bulgular: Diyabetiklerde serum siyalik asit düzeyi (R0=2.00±0.47, R1=2.17±0.30, R2=2.25±0.5 mmol/L), sağlıklı kontrollerle (K=1.81±0.30 mmol/L) karşılaştırıldığında anlamlı olarak yüksek bulundu (P 0.05).

🔖

Cite This Article

ÜSTÜNDAĞ, Y., AKDOĞAN, M., DEMİRCİ, H., İBİŞ, Ş. S., YAVUZ, D., KOSKU, N. (2003). The relation between sialic acid elevation and retinopathy in type II diabetic patients. Retina-Vitreus, Cilt: 11 - Sayı: 3, 235–242. https://ajindex.com/articles/307949

References (15)

  1. Fong D.S, Asello L, Gardner TW et al: Diabetic retinopathy. Diabetes Care. 1999
  2. 26 supp 1 2. Taniuchi K5 Chifu K, Hayashi N et al: A new enzymatic method for the determination of sialic acid and its application as a marker of acute phase reactants. Kobe J. Med Sei. 1981
  3. Levinsky H, Rothman G, Lapidot M et al: Red blood cell membrane and serum sialic acid in relation to erythrocyte sedimentation rate. Acta Haemat 1980
  4. Sillanaukee P, Pönniö M, Jaaskelainen IP:Occurance of sialic acids in healthy humans and different disorders. Eur. J. Clin. Investig. 1999
  5. Doğan H, Paşaoğlu H, Ekinciler ÖF et al: A comparative study of total protein, total and lipid associated serum acid levels in patients with Behçet's disease and control groups. Acta ophthalmologica 1992
  6. Crook MA, Tutt P, Simpson H et al: Serum sialic acid and acute phase proteins in type 1 and type2 diabetes mellitus.Clin Chim Acta 1993
  7. Crook MA, Tutt P, Pickup JC: Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy. Diabetes Care 1993
  8. Radhakrishnamurty B, Beenson GS, Pargoonkar PS et al: Serum free and protein-bound sugars and cardiovascular complications in diabetes mellitus. Lab.lnvest 1976
  9. Tomino Y, Inove W, Yagame M et al: Measurement of sialic acid and acute phase reactant proteins in sera of patients with diabetic nephropathy. J.Diabetic Complications. 1998
  10. Chen JW, Gall MA, Yokoyama H et al: Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy. Diabetes care. 1996
  11. Niaz İ, Fahat K, Chusney GD et al: Ethnic differences in corraletes of microalbuminu'ria in NIDDM.The role of acute-phase response. Diabetes Care 1998
  12. Alberti KGMM, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications.Part 1.Diagnosis and classification of diabetes mellitus.Provisional report of a WHO consultation. Diabet.Med.1998
  13. Crook M, Hag M, Tutt P: Evaluation of three assays for the determination of serum total sialic acid. Clin.Biochem. 1993
  14. Ekin S, Meral I, Gündüz H et al: Comparative study of total protein and total and lipid-associated sialic acid levels in patients with type 2 diabetes mellitus. J.CIin.Lab.Anal.2003
  15. Campas SP, Baumann H: Insulin is a prominent modulator